Ultragenyx Pharmaceutical Inc (RARE)

12:03 PM

Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE) - Insider Monkey

12:03 PM

Jun 04, 2026

Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm - PR Newswire

Jun 04, 2026

Jun 04, 2026

Ultragenyx EVP and chief medical officer Crombez sells $8,586 in shares - Investing.com

Jun 04, 2026

Jun 04, 2026

Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Jun 04, 2026

Jun 03, 2026

Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times

Jun 03, 2026

Jun 03, 2026

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year - AOL.com

Jun 03, 2026

Jun 01, 2026

Insider Sell: Howard Horn Sells Shares of Ultragenyx Pharmaceuti - GuruFocus

Jun 01, 2026

Jun 01, 2026

Ultragenyx CFO Horn sells $110,601 in company stock By Investing.com - Investing.com Australia

Jun 01, 2026

Jun 01, 2026

Insider Selling: Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Sells 4,653 Shares of Stock - MarketBeat

Jun 01, 2026

Jun 01, 2026

Ultragenyx CFO Horn sells $110,601 in company stock - Investing.com

Jun 01, 2026

Jun 01, 2026

Ultragenyx Pharmaceutical (RARE) CFO sells 4,653 common shares - Stock Titan

Jun 01, 2026

May 25, 2026

Jefferies Financial Group Inc. Takes $10.97 Million Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

May 25, 2026

May 25, 2026

Blue Owl Capital Holdings LP Decreases Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

May 25, 2026

May 24, 2026

Northwestern Mutual Wealth Management Co. Has $4.63 Million Stock Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

May 24, 2026

May 24, 2026

Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

May 24, 2026

May 24, 2026

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 24, 2026

May 23, 2026

J.P. Morgan Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $72 - Moomoo

May 23, 2026

May 22, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 22, 2026

May 22, 2026

Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $1.41 Million in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

May 22, 2026

May 21, 2026

Cantor Fitzgerald raises Ultragenyx stock price target on therapy outlook By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

RARE Maintained by Cantor Fitzgerald -- Price Target Raised to $96 - GuruFocus

May 21, 2026

May 21, 2026

Cantor Fitzgerald Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price - MarketBeat

May 21, 2026

May 21, 2026

Ultragenyx Pharmaceutical’s SWOT analysis: stock faces pivotal trial results By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

Cantor Fitzgerald raises Ultragenyx stock price target on therapy outlook - Investing.com

May 21, 2026

May 21, 2026

Ultragenyx Pharmaceutical’s SWOT analysis: stock faces pivotal trial results - Investing.com

May 21, 2026

May 20, 2026

Ultragenyx Earnings Call Balances Growth and Cash Burn - TipRanks

May 20, 2026

May 19, 2026

Ultragenyx Shareholders Approve Incentive Plan, Elect Directors - The Globe and Mail

May 19, 2026

May 19, 2026

Ultragenyx director Suliman Shehnaaz sells $144,188 in stock By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

Ultragenyx Pharmaceutical stock (US74930A1043): Shareholders back incentive plan - AD HOC NEWS

May 19, 2026

May 18, 2026

Ultragenyx director Suliman Shehnaaz sells $144,188 in stock - Investing.com UK

May 18, 2026

May 18, 2026

Ultragenyx (RARE) director receives RSU and stock option grants in new Form 4 - Stock Titan

May 18, 2026

May 18, 2026

Ultragenyx (RARE) director sells shares and receives RSU and option awards - Stock Titan

May 18, 2026

May 18, 2026

Ultragenyx (RARE) director granted RSUs and stock options as compensation - Stock Titan

May 18, 2026

May 18, 2026

Ultragenyx (RARE) director receives RSU and stock option grants - Stock Titan

May 18, 2026

May 18, 2026

Ultragenyx (RARE) director Narachi receives RSU and option awards - Stock Titan

May 18, 2026

May 18, 2026

[Form 4] Ultragenyx Pharmaceutical Inc. Insider Trading Activity - Stock Titan

May 18, 2026

May 18, 2026

Ultragenyx (RARE) director Deborah Dunsire granted RSUs and new stock options - Stock Titan

May 18, 2026

May 18, 2026

[144] Ultragenyx Pharmaceutical Inc. SEC Filing - Stock Titan

May 18, 2026

May 18, 2026

Ultragenyx shareholders approve director elections and incentive plan at annual meeting - Investing.com Nigeria

May 18, 2026

May 18, 2026

Ultragenyx (RARE) investors approve incentive plan, board slate and 2026 auditor - Stock Titan

May 18, 2026

May 17, 2026

Rare Q1 loss wider than expected, sales down Y/Y on seasonal effect - MSN

May 17, 2026

May 16, 2026

Chancery Court Tosses Stockholder Complaint Against Ultragenyx Pharma - Courthouse News

May 16, 2026

May 15, 2026

Ultragenyx Pharmaceutical Inc.Common Stock (NQ: RARE - The Chronicle-Journal

May 15, 2026

May 15, 2026

Ultragenyx Pharmaceutical Sees Unusually Large Options Volume (NASDAQ:RARE) - MarketBeat

May 15, 2026